Publicacions
-
Besoaín AM, Gil MM, Alouali-Moussakhkhar M, Baladon L, Sáez J and Rubio-Valera M.
Exploring lived experiences in home-based psychiatric care: a qualitative study of service users, families, and professionals in Spain.
Frontiers in Psychiatry . 16: 1670470-1670470.
-
Paut Kusturica M, Sanchez A, Lumbreras B, Huerta-Ramos ME, Aznar I and Rubio-Valera M.
Assessing direct medical costs of children following a new prescription of ADHD medication.
BMC HEALTH SERVICES RESEARCH . 25(1): 990-990.
-
Osorio D, Plana MN, Rubio-Valera M, Muñoz-Miguel J, Bolíbar I, Franco MT, Secanell-Espluga M, Soler M, Fernández-Torres P, Suclupe S, Salas-Gama K, Torres-López D and Ferreira-González I.
Patient-Reported Incident Measure (PRIM) tools for reporting patient safety incidents: protocol for a scoping review.
BMJ Open . 15(6): .
-
Rubio-Valera M, Carbonell-Duacastella C, Peñarrubia-María MT, Pacheco E, Gabriela-Ricciardeli P, Aznar I and Gil MM.
Insights on pediatric medication initiation: perceptions of caregivers and children.
FRONTIERS IN PHARMACOLOGY . 16: 1612169-1612169. Nº de cites: 1
-
Andersohn F, Christensen MC, Creuwels L, Aznar I, Rubio-Valera M, Penning-van Beest F, Houben E, Hernandez P, Hakkarainen KM and Reines EH.
Vortioxetine in the routine management of major depressive disorder: an analysis of European automated healthcare databases.
CURRENT MEDICAL RESEARCH AND OPINION . 41(5): 867-877.
-
Fuente M, Cahir C, Passos VL, Bennett K, Walsh C, Hermida-González P, Peláez de Loño J, Abella MER, Baladon L, Rubio-Valera M, Serrano-Blanco A and Aznar I.
Identifying longitudinal medication adherence patterns of antipsychotic treatments: A real-world cohort study in Catalonia, Spain
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . : . Nº de cites: 1
-
Vargas I, Mogollón-Pérez AS, Eguiguren P, Torres AL, Peralta A, Rubio-Valera M, Jervelund SS, Borras JM, Dias S and Vázquez ML.
Understanding the health system drivers of delayed cancer diagnosis in public healthcare networks of Chile, Colombia and Ecuador: A qualitative study with health professionals, managers and policymakers.
SOCIAL SCIENCE & MEDICINE . 365: 117499-117499. Nº de cites: 1
-
Sebastián D, Beltrà M, Irazoki A, Sala D, Aparicio-García P, Aris C, Alibakhshi E, Rubio-Valera M, Palacín M, Castellanos J, Lores L and Zorzano A.
TP53INP2-dependent activation of muscle autophagy ameliorates sarcopenia and promotes healthy aging
Autophagy . 20(8): 1815-1824. Nº de cites: 9
-
Chavarría V, Rubio-Valera M, Domènech J, Baladon L, Mateu I, Arias de la Torre J, Alvarós J, Peña C, Dima AL and Serrano-Blanco A.
Patient Satisfaction and Willingness to Continue with Telemental Health Care During and After the Early Period of SARS-CoV-2 Pandemic: A User Survey
TELEMEDICINE AND E-HEALTH . 30(7): 1935-1943.
-
Fuente M, Dima AL, Rubio-Valera M, Baladon L, Chavarría V, Fabrizio S, Peña C, Serra-Sutton V, Hermida-González P, de Loño JP, Rey-Abella ME, Aznar I and Serrano-Blanco A.
Evaluation of adherence to antipsychotics: A real-world data study using four different dosing assumptions
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . 90(6): 1480-1492. Nº de cites: 2
